Literature DB >> 31899703

Impact of β-Blockers on Heart Rate and Oxygen Uptake During Exercise and Recovery in Older Patients With Heart Failure With Preserved Ejection Fraction.

Sara Maldonado-Martín1, Peter H Brubaker, Cemal Ozemek, Jon A Jayo-Montoya, J Thomas Becton, Dalane W Kitzman.   

Abstract

PURPOSE: The study aimed to investigate the differences in oxygen uptake ((Equation is included in full-text article.)O2) and heart rate (HR) (at rest, submaximal exercise, peak exercise, and recovery) in patients with heart failure with preserved ejection fraction (HFpEF) with β-blockers (BB) or without BB treatment (NBB) and to analyze the relationship between HR reserve (HRresv) and peak (Equation is included in full-text article.)O2 ((Equation is included in full-text article.)O2peak) in BB and NBB.
METHODS: A total of 174 HFpEF patients (>65 yr; BB, n = 59; NBB, n = 115) were assessed with a cardiopulmonary exercise test to peak exertion using an incremental protocol. After 5 min of supine rest, HR and (Equation is included in full-text article.)O2 (HRrest, (Equation is included in full-text article.)O2rest) at submaximal exercise (HRsubmax, (Equation is included in full-text article.)O2submax), at peak exercise (HRpeak, (Equation is included in full-text article.)O2peak), at 1 min of passive recovery (HRrec1), HRresv (HRpeak- HRrest), and HR recovery (HRrecov = HRpeak- HRrec1) were evaluated.
RESULTS: Analysis showed that HRrest (66.0 ± 12.2 vs 69.7 ± 10.6 bpm), HRsubmax (91.7 ± 16.2 vs 98.6 ± 15.2 bpm), and HRrec1 (102.9 ± 18.9 vs 109.4 ± 16.9 bpm) were significantly lower (P ≤ .05) in BB than in NBB, respectively. However, there were no significant differences (P > .05) between the BB and the NBB for HRpeak, HRresv, HRrecov, (Equation is included in full-text article.)O2rest, (Equation is included in full-text article.)O2submax, and (Equation is included in full-text article.)O2peak. A significant relationship was found between HRresv and (Equation is included in full-text article.)O2peak values in both groups (BB, r = 0.52; NBB, r = 0.49, P < .001).
CONCLUSIONS: The nonsignificant differences in HRpeak, HRresv, HRrecov, or (Equation is included in full-text article.)O2 values between BB and NBB HFpEF patients, along with significant correlation between HRresv and (Equation is included in full-text article.)O2peak, suggest that these measures may have equal utility in prognostic and functional assessment as well as clinical applications, including the prescription of exercise, in elderly HFpEF patients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31899703      PMCID: PMC7682249          DOI: 10.1097/HCR.0000000000000459

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   3.646


  26 in total

1.  Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.

Authors:  Viviane M Conraads; Marco Metra; Otto Kamp; Gilles W De Keulenaer; Burkert Pieske; José Zamorano; Panos E Vardas; Michael Böhm; Livio Dei Cas
Journal:  Eur J Heart Fail       Date:  2011-12-06       Impact factor: 15.534

2.  Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Authors:  Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

Review 3.  Role of physical training in heart failure with preserved ejection fraction.

Authors:  Mark Haykowsky; Peter Brubaker; Dalane Kitzman
Journal:  Curr Heart Fail Rep       Date:  2012-06

4.  Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2010-06-11       Impact factor: 8.790

Review 5.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

6.  Reference Standards for Cardiorespiratory Fitness Measured With Cardiopulmonary Exercise Testing Using Cycle Ergometry: Data From the Fitness Registry and the Importance of Exercise National Database (FRIEND) Registry.

Authors:  Leonard A Kaminsky; Mary T Imboden; Ross Arena; Jonathan Myers
Journal:  Mayo Clin Proc       Date:  2016-12-07       Impact factor: 7.616

7.  Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace?

Authors:  Ulrich P Jorde; Timothy J Vittorio; Michael E Kasper; Emma Arezzi; Paolo C Colombo; Rochelle L Goldsmith; Kartikya Ahuja; Chi-Hong Tseng; Francois Haas; David S Hirsh
Journal:  Eur J Heart Fail       Date:  2007-12-21       Impact factor: 15.534

8.  Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.

Authors:  Kanan Patel; Gregg C Fonarow; O James Ekundayo; Inmaculada B Aban; Meredith L Kilgore; Thomas E Love; Dalane W Kitzman; Mihai Gheorghiade; Richard M Allman; Ali Ahmed
Journal:  Int J Cardiol       Date:  2014-03-11       Impact factor: 4.164

9.  Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.

Authors:  Gema Ruiz; Jose L Andrey; Jose L Puerto; Miguel A Escobar; Sotero P Romero; Rocio Aranda; María J Pedrosa; Francisco Gomez
Journal:  Int J Cardiol       Date:  2016-08-03       Impact factor: 4.164

Review 10.  Chronotropic incompetence: causes, consequences, and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 39.918

View more
  2 in total

1.  Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism.

Authors:  Payman Zamani; Elizabeth A Proto; Neil Wilson; Hossein Fazelinia; Hua Ding; Lynn A Spruce; Antonio Davila; Thomas C Hanff; Jeremy A Mazurek; Stuart B Prenner; Benoit Desjardins; Kenneth B Margulies; Daniel P Kelly; Zoltan Arany; Paschalis-Thomas Doulias; John W Elrod; Mitchell E Allen; Shana E McCormack; Gayatri Maria Schur; Kevin D'Aquilla; Dushyant Kumar; Deepa Thakuri; Karthik Prabhakaran; Michael C Langham; David C Poole; Steven H Seeholzer; Ravinder Reddy; Harry Ischiropoulos; Julio A Chirinos
Journal:  ESC Heart Fail       Date:  2021-05-15

2.  The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise.

Authors:  Eldar Priel; Mustafaa Wahab; Tapas Mondal; Andy Freitag; Paul M O'Byrne; Kieran J Killian; Imran Satia
Journal:  Curr Res Physiol       Date:  2021-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.